Terminally alkylated heparin. 1. Antithrombogenic surface modifier.

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Biomedical Engineering

Background:

• Heparin is a crucial anticoagulant used in medical devices.
• Improving the surface properties of materials for medical devices is essential for patient safety.
• Current methods for heparin immobilization may have limitations in stability and efficacy.

Purpose of the Study:

• To synthesize and characterize terminally alkylated heparin derivatives.
• To evaluate the adsorption, stability, and antithrombotic properties of these modified heparins.
• To explore their potential application as "heparin surfactants" for medical devices.

Main Methods:

• Heparin was chemically modified through terminal alkylation using various alkylamines (butyl, octyl, lauryl, stearyl).
• Alkylated heparins were adsorbed onto poly(ethylene terephthalate) films.
• Adsorption, stability in buffer, and complexation with antithrombin III (ATIII) were assessed.
• Confocal laser scanning microscopy was employed for evaluation.

Main Results:

• Successful synthesis of terminally alkylated heparins with varying alkyl chain lengths.
• Enhanced adsorption and stability of alkylated heparins on PET films with increasing alkyl chain length.
• Improved compatibility with antithrombin III (ATIII) for longer alkyl chains.
• Demonstrated potential for short-term system antithrombogenicity.

Conclusions:

• Terminally alkylated heparins function as effective "heparin surfactants."
• The degree of alkylation significantly influences adsorption, stability, and antithrombotic efficacy.
• These modified heparins offer a promising approach for short-term antithrombogenicity in extracorporeal circuits.